The AKI-SP2 subgroup characterized by elevated Angiopoietin-2/Angiopoietin-1 ratio had a ~ 2.5-fold higher risk of 28-day mortality and increased risk of renal non-recovery, relative to patients with AKI-SP1. Here, ANGPT2 is linked to acute kidney injury.